| All Reports (Showing 1 to 10 of 19) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
StarMine Author Rating | More Info |
| EPS Accuracy * |
Portfolio Return ** |
| 8-Feb-10 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | | View Abstract |
| 8-Feb-10 | PriceTarget Research, Inc. | N/A | Trinity Biotech PLC has a current Overall Rating of C (Neutral). | 7 | $25 | | | View Abstract |
| 2-Feb-10 | EconomicInvestor | N/A | "The Economy Matters" Report for TRIB: the economy's impact on TRIB's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 | $15 | | | View Abstract |
| 31-Jan-10 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC | 5 | $25 | | | View Abstract |
| 24-Jan-10 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC | 5 | $25 | | | View Abstract |
| 20-Jan-10 | Zacks Investment Research Inc. | N/A | TRINITY BIOTECH (TRIB) Zacks Company Snapshot | 1 | $10 | | | View Abstract |
| 17-Jan-10 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC | 5 | $25 | | | View Abstract |
| 13-Jan-10 | Life Science Analytics | Life Science Analytics | Trinity Biotech Plc-Company Report | 21 | $150 | | | View Abstract |
| 6-Jan-10 | Roth Capital Partners, Inc. | Matt Dolan | 4Q 2009: Quarterly Medical Device Trading & Acquisition Valuation Update | 8 | $25 | | | View Abstract |
| 6-Jan-10 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 14 | $50 | | | View Abstract |